Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid, Bruker, and Qiagen Shares All Rise in Double Digits

The stocks of Cepheid, Bruker BioSciences, and Qiagen all gained more than 10 percent for the five-day trading period ended Tuesday.
 
Cepheid led all gainers in the BCW Index for the week with a 12.6 percent rise in its shares. The firm is due to report its third-quarter results on Nov. 1.
 
Bruker BioSciences shares bumped up 11.6 percent after the firm posted strong revenue and profit gains earlier this week. Shares of Qiagen hit a new 52-week high of $23.65 on Tuesday before closing at $23.55, up 11.1 percent for the tracking period.
 
Illumina led all declining shares in the Index with a drop of 10.3 percent for the week. Shares of Affymetrix, which filed additional patent infringement suits against Illumina last week (see Briefs), fell 9.2 percent.
 
Overall, the Index declined .8 percent. The Dow Jones Industrial Average gained .8 percent for the tracking period, while the Nasdaq rose .6 percent, and the Nasdaq Biotech Index dropped .3 percent.
 
 


BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(October 30, 2007)
Last
Price
(October 23, 2007)
% change
Affymetrix
AFFX
24.80 27.31 -9.19
Agilent
A
35.86 37.33 -3.94
Applied Biosystems
ABI
36.01 35.22 2.24
Beckman
BEC
70.14 73.86 -5.04
Becton Dickinson
BDX
83.44 81.77 2.04
Bio-Rad
BIO
95.36 95.07 0.31
Bruker
BRKR
10.17 9.11 11.64
Caliper
CALP
5.85 5.85 0.00
Cepheid
CPHD
26.07 23.15 12.61
Illumina
ILMN
55.93 62.38 -10.34
Invitrogen
IVGN
83.07 84.30 -1.46
Luminex
LMNZ
16.54 16.33 1.29
MDS
MDZ
22.14 21.96 0.82
Millipore
MIL
74.80 74.50 0.40
PerkinElmer
PKI
27.83 29.50 -5.66
Qiagen
QGEN
23.55 21.20 11.08
Sequenom
SQNM
9.67 10.58 -8.60
Sigma-Aldrich
SIAL
50.95 50.11 1.68
Thermo
TMO
58.13 59.51 -2.32
Third Wave
TWTI
9.43 9.59 -1.67
Waters
WAT
75.22 73.92 1.76
BCW Index Average 42.62 42.98 -0.84
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.